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on the accuracy of administrative data for carotid
endarterectomy and stenting
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Background: Administrative data are often hampered by coding errors, absent data, and the difﬁculty of distinguishing
pre-existing conditions from perioperative complications. We evaluated whether the introduction of the present on
admission (POA) indicator improved outcome analysis of carotid endarterectomy (CEA) and carotid angioplasty and
stenting (CAS) using administrative data.
Methods: State inpatient databases from California (2005-2008), New York (2008), and New Jersey (2008) were used to
identify patients undergoing CAS and CEA. We ﬁrst analyzed morbidity data without the POA indicator, using Inter-
national Classiﬁcation of Diseases, Ninth Revision complication codes (eg, 997.02, iatrogenic cerebrovascular infarction
or hemorrhage, postoperative stroke) and diagnosis codes (eg, 433.11, occlusion and stenosis of the carotid artery with
cerebral infarction). Then, we applied the POA indicator to both diagnosis and complication codes and calculated the
proportion of events that were labeled POA. Symptom status and perioperative stroke rate were compared using these
coding approaches.
Results: We identiﬁed 21,639 patients who underwent CEA and 3688 patients who underwent CAS. Without the POA
indicator, the complication code for stroke indicated a postoperative stroke rate of 1.4% for CEA and 2.4% for CAS. After
applying the POA indicator, 54% (CEA) and 62% (CAS) of these strokes were labeled POA. These POA strokes were
either preoperative or intraoperative events. Proportion of symptomatic patients ranged from 7% to 16% for CEA and
from 5% to 22% for CAS. Perioperative stroke rate was the lowest in the POA method (1.1% CEA, 1.8% CAS) compared
with two other methods without POA information (1.4% and 9.5% CEA and 2.4% and 16.4% CAS). Kappa indicated
a poor (0.2) to fair (0.7) agreement between these approaches.
Conclusions: Administrative data has known limitations for assignment of symptom status and nonfatal perioperative
outcomes. Given the uncertain timing of POA events as preoperative vs intraoperative and its apparent underestimation
of the perioperative stroke rate, the use of administrative data even with the POA indicator for symptom status and non-
fatal outcomes after CEA and CAS is hazardous. (J Vasc Surg 2014;59:32-8.)The use of administrative data to analyze population-
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://dx.doi.org/10.1016/j.jvs.2013.07.006been called into question.1,2 Despite the beneﬁt of large
patient samples, administrative data are often hampered
by coding errors, absent data, and the difﬁculty of distin-
guishing pre-existing conditions from postoperative
complications. More speciﬁcally, stroke may be either the
indication for revascularization of a symptomatic carotid
stenosis, or an adverse event after carotid angioplasty and
stenting (CAS) or carotid endarterectomy (CEA). Such
misclassiﬁcation may lead to under- or overestimating
both the proportion of symptomatic patients and the
number of perioperative complications. Previous compari-
sons of CAS and CEA utilizing administrative data have
been further limited by a lack of standardized outcome
deﬁnitions. While some reports considered only complica-
tion codes (eg, 997.02 iatrogenic cerebral infarction or
hemorrhage - postoperative stroke) to identify postopera-
tive strokes, others included diagnosis codes (eg, 434.11
cerebral embolism with cerebral infarction) as well.3-5 A
present on admission (POA) indicator has been developed
to improve coding accuracy beyond the standard Interna-
tional Classiﬁcation of Diseases, Ninth Revision, Clinical
Modiﬁcation (ICD-9-CM) diagnosis and complication
codes. When the Centers for Medicare and Medicaid
Services implemented a new pay-for-performance policy
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conditions be identiﬁed as POA in patient discharge
abstracts. Whereas hospitals would not be penalized for
pre-existing conditions designated as POA, management
of 10 prespeciﬁed hospital-acquired conditions (stroke
not included), those without a POA identiﬁer, would be
nonreimbursable and ineligible for contribution to higher
reimbursement diagnosis-related groups.6 The reﬁnement
of administrative claims data through the addition of
a POA indicator has been shown to improve the validity
of surgical outcome measures, as investigated by prior
studies.7-10 However, the impact of the new POA method-
ology has not yet been evaluated for carotid interventions.
Therefore, we utilized the State Inpatient Databases (SID),
which consist of inpatient hospital discharge abstracts in
participating states (about 90% of all U.S. hospital
discharges) translated into a uniform format containing
a core set of clinical and nonclinical information on all
patients, regardless of payer. Our aim was to investigate
the impact of the POA indicator on administrative data
in order to evaluate outcomes of CAS and CEA.
METHODS
Database. The SID from three states (California
2005-2008, New York 2008, and New Jersey 2008)
were used to identify patients undergoing CEA and CAS.
Database selection was made based upon data availability
and sample size. Our inclusion criteria generated a study
population >25,000 patients, which is comparable to other
population based studies in the ﬁeld.11,12 The SID is
a component of the Healthcare Cost and Utilization
Project produced by the Agency for Healthcare Research
and Quality and captures all hospitalizations that occur in
community and academic hospitals in the participating
states.13 Quality and comparison reports of the data are
available online (http://www.hcup-us.ahrq.gov). Effective
October 1, 2007, the Hospital Uniform Bill was enacted,
which set forth speciﬁc data requirements for hospital
claims including a POA indicator for each diagnosis ﬁeld.
However, pioneering the practice in the 1990s, New York
and California were early adopters of the POA indicator
and required to report POA information in all in hospital
discharge data as of that time. Thus, the POA indicator was
a requirement for all included states during the study
period. For the purposes of the POA indicator, hospitals
code (using a uniform format across all states) any condi-
tions the patient has at the time of inpatient admission as
POA. Medical record documentation from any provider
involved in the care and treatment of the patient may be
used to support the determination of whether a condition
was POA. Hospitals and other facilities are required to use
a standardized set of requirements and deﬁnitions to report
the POA indicator as delineated in the Ofﬁcial UB-04
Data Speciﬁcations Manual and the ICD-9-CM Ofﬁcial
Guidelines for Coding and Reporting.
Data retrieval. The SID was queried for patient selec-
tion using both ICD-9-CM procedure and diagnosis codes.
Patients undergoing CEA (38.12) and CAS (00.61, 00.63)were identiﬁed. Patients undergoing cardiac procedures
during the same hospital stay were excluded (coronary
artery bypass, cardiac valve repair, percutaneous coronary
artery intervention, or a diagnostic cardiac catheterization).
To ensure accurate coding on POA information, patients
were selected with at least one diagnosis listed as POA.
ICD-9 diagnosis codes include a separate set of codes for
“complications of surgical and medical care, not elsewhere
classiﬁed.” For the purpose of this manuscript we will refer
to these codes as “complication codes,” as others have done
previously.1 We used all diagnosis and complication codes
(in each diagnosis ﬁeld) that potentially represent comor-
bidities or outcome following carotid revascularization, as
speciﬁed in the Supplementary Table I, online only. Codes
were obtained by a thorough review of the coding literature
and include all codes that were previously used for carotid
interventions.
POA deﬁned. POA is deﬁned as any condition present
at the time the inpatient admission order is placed. For
carotid revascularization procedures, POA codes can refer
to different events depending on the speciﬁc order of
events for a particular patient. If the patient is admitted
to the hospital prior to carotid revascularization, a POA
event refers to a preoperative, prehospital condition (eg,
a complication stroke coded as POA will refer to a symp-
tomatic patient). However, when the inpatient order is
written after the procedure (eg, same day admission
patients scheduled for elective procedures), a POA event
most likely refers to an intraoperative event. In the latter
scenario, it is unclear which event or condition was present
before the operation and which events were complications
during procedures.
Data analyses. For all patients undergoing CAS or
CEA, frequencies and event rates for potential preadmis-
sion comorbidities and perioperative outcomes were calcu-
lated using diagnosis and complication codes without the
application of the POA information. We then analyzed
these rates in the presence of the POA information, which
was applied on those same diagnosis and complication
codes. The proportion of events that were POA and revised
rates for each event were calculated, distinguishing the rate
of “POA event rate” from “non-POA event rate.” Subse-
quently, the proportion of symptomatic patients and post-
operative stroke rate in symptomatic and asymptomatic
patients was evaluated using three different previously
described methodologies.3-5,14 While the ﬁrst method (A)
uses the complication code for stroke to identify peri-
operative stroke, the second method (B) uses diagnosis
codes for stroke together with the complication code for
stroke to identify perioperative stroke (Table I). In
administrative data that contains POA information, a third
methodology (POA) was used.11 Under the assumption
that a complication code of stroke with a POA label
refers to a preprocedural condition, preoperative symptom
status could be identiﬁed using both diagnosis and
complication codes for neurologic symptoms (stroke,
transient ischemic infarction, amaurosis fugax)5 with the
POA ﬂag (Supplementary Table II, online only). Patients
Table I. Different methodologies to identify symptom
status and perioperative stroke rate using administrative
data
Symptom status Perioperative stroke
Method A Diagnosis codes for stroke,
TIA, and amaurosis fugax
Complication code
for stroke
Method B Diagnosis codes for TIA
and amaurosis fugax
Diagnosis codes and
the complication
code for stroke
Method
POA
Diagnosis codes for stroke,
TIA, and amaurosis fugax
and the complication code
for stroke with POA label
Diagnosis codes and
complication code
without POA label
POA, Present on admission; TIA, transient ischemic infarction.
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considered asymptomatic. Perioperative outcomes include
both diagnosis codes and the complication code for stroke
in the absence of POA ﬂags. We calculated Cohen’s Kappa
(L) to measure agreement of method A and B with the
POA method to identify symptom status and perioperative
stroke rate. Kappa values of >0.75 indicate excellent
agreement between methodologies, 0.4-0.75 indicate fair
to good agreement, and values <0.4 indicate poor agree-
ment. In addition, mortality rates and stroke-to-death
ratios were investigated.
Queries of the SID data were performed with SAS v
9.2. (SAS Institute, Cary, NC). IBM SPSS v 19.0 (IBM
Corporation, Armonk, NY) was used for all statistical
analyses.
RESULTS
A total of 41,684 patients were identiﬁed who under-
went CEA (n ¼ 36,002; 86.4%) or CAS (n ¼ 5682;
13.6%); 60.7% of those patients had at least one diagnosis
listed as POA, resulting in a ﬁnal study sample of 25,327
patients including 21,639 (85.4%) undergoing CEA and
3688 (14.6%) undergoing CAS.
The proportions of comorbidities and adverse
events that were POA. Without POA information, diag-
nosis codes for stroke were found in 9.1% (n ¼ 1960) of
those undergoing CEA and 15.6% (n ¼ 574) of those
undergoing CAS. After applying the POA information,
90.3% (CEA) and 91.3% (CAS) of these strokes were
labeled POA (Tables II and III). The complication code
for stroke was present in 1.4% (n ¼ 296) of patients
undergoing CEA and 2.4% (n ¼ 87) of patients who
underwent CAS. In 54% of CEA and in 62% of CAS
patients, these strokes were labeled as POA. The vast
majority of diagnosis codes for other neurologic or acute
cardiac diagnoses such as transient ischemic infarction,
amaurosis fugax, and acute myocardial infarction were
POA. The cardiac complication code was designated POA
in 58% of CEA and 62% of CAS. Conditions that are infre-
quently encountered after carotid interventions, but are
more likely to represent a postoperative complication than
a pre-existing condition, were most impacted by the POAindicator: between 40% and 61% of peripheral vascular
complications, respiratory complications, pneumonia and
acute renal failure diagnosis were labeled POA for both CEA
and CAS. Conditions that are regularly pre-existing condi-
tions were correctly designated as being POA in more than
88% of diagnoses.
Deﬁning preoperative symptom status using admin-
istrative data. Of the CEA patients, 15.9% (n ¼ 3436)
were considered symptomatic using method A (no POA
information) and 7.1% (n ¼ 1540) using method B (no
POA information). In method POA, 15.4% (n ¼ 3324) of
CEA patients were considered symptomatic (Table IV).
Kappa indicated an excellent agreement between method A
compared with method POA (0.96), while a fair agreement
(0.57) was seen between method B and method POA.
Among CAS patients, 21.7% (n ¼ 801) of patients
were symptomatic using method A, 4.6% (n ¼ 243)
using method B, and 21.0% (n ¼ 776) using method
POA. Similar to CEA, kappa indicated an excellent agree-
ment between method A and method POA (0.95) and
a fair agreement (0.40) between method B and method
POA.
Deﬁning perioperative stroke and mortality using
administrative data. Following CEA, the perioperative
stroke rate was 1.4% (5.9% symptomatic and 0.5% asymp-
tomatic) using method A. Using method B, the periopera-
tive stroke rate was 9.5% (4.8% symptomatic and 9.9%
asymptomatic). Using method POA, the perioperative
stroke rate was 1.1% (2.5% symptomatic and 0.9% asymp-
tomatic) (Table V). Between method A and method
POA, kappa indicated a fair agreement in the identiﬁcation
of postoperative strokes (kappa 0.7). Although the stroke
rate in method A (1.4%; n ¼ 296) and method POA (1.1%;
n ¼ 247) was fairly similar, 23.9% (n ¼ 59) of strokes that
were designated as perioperative events with the POA
method were not picked up as perioperative strokes with
method A. Similarly, method A designated 36.5% (n ¼
108) of strokes as perioperative events, while these strokes
were pre-existing with the POA methodology. Method B
clearly identiﬁes all strokes that were found using method
POA, but 88% (n ¼ 1817) of these strokes were designated
as being POA with the POA method. A kappa of 0.2
showed poor agreement between method B and method
POA. Mortality for all patients was 0.5% and varied
between symptomatic and asymptomatic patients accord-
ing to the different methodologies that were applied
(Table V). Using the POA method, death rate was 1.3%
and stroke-to-death ratio was 1.9:1 for symptomatic
patients, while death rate in asymptomatic patients was
0.4% and stroke-to-death ratio 2.5:1.
Following CAS, the perioperative stroke rate was 2.4%
(7.5% symptomatic and 0.9% asymptomatic) using method
A. Using method B, the perioperative stroke rate was
16.4% (8.4% symptomatic patients and 11.4% asymptom-
atic). Using method POA, the perioperative stroke rate
was 1.8% (3.4% symptomatic and 1.6% asymptomatic
patients) (Table V). Similar inaccuracies and agreements
between the three methodologies were identiﬁed as after
Table II. Frequencies of diagnosis and complication codes used in the State Inpatient Databases of California, New York,
and New Jersey in 21,639 patients undergoing carotid endarterectomy (CEA) and the impact of the present on admission
(POA) indicator on preoperative conditions and perioperative outcome
Rates identiﬁed without
POA indicator Proportion POAa
Revised rates with
POA indicator
% No. % No. POA rate,b % Non-POA rate,c %
Major neurologic or acute cardiac diagnoses that may represent either pre-existing conditions or complications after intervention
Stroke
Diagnosis code 9.1 1960 90.3 1770 8.2 0.9
Complication code 1.4 296 53.7 159 0.7 0.6
Transient ischemic attack 3.1 665 94.9 631 2.9 0.2
Amaurosis fugax 4.2 905 98.0 887 4.1 0.1
Cardiac complication 2.8 609 58.3 355 1.6 1.2
Acute myocardial infarction 2.4 509 70.3 358 1.7 0.7
Conditions that are infrequently encountered after intervention
Peripheral vascular complication 0.1 18 61.1 11 0.1 0.0
Respiratory complication 0.7 151 45.0 68 0.3 0.4
Pneumonia 1.6 337 54.6 184 0.9 0.7
Acute renal failure 2.4 527 60.0 316 1.5 1.0
Conditions that are regularly pre-existing comorbidities
Coronary artery disease 29.4 6369 97.3 6195 28.6 0.8
Angina 1.4 313 88.2 276 1.3 0.2
Congestive heart failure 11.2 2414 91.3 2203 10.2 1.0
Chronic obstructive pulmonary disease 27.3 5918 96.6 5719 26.4 3.4
Chronic kidney disease 11.5 2495 96.7 2412 11.1 0.4
Diabetes 49.9 10,801 97.5 10,526 48.6 1.3
aOf the rates that were identiﬁed without the use of the POA indicator.
bCondition ﬂagged POA.
cCondition not ﬂagged POA.
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method POA) and 0.2 (method B and method POA).
DISCUSSION
In this study, we examined the impact of the POA indi-
cator on the accuracy of administrative data to evaluate
outcome after CAS and CEA. While the majority of diag-
nosis codes represented conditions that were POA, we
found that nearly one-half of complication codes were
coded as POA. Our evaluation of the POA indicator iden-
tiﬁed several ﬂaws with the use of this method as well as the
others, indicating that the use of administrative data for
carotid outcome analysis is limited.
A major limitation of the POA indicator is its variable
designation of intraoperative strokes as either pre-existing
or perioperative complications depending on the timing
of admission order placement. Most elective carotid proce-
dures will be scheduled as same-day admissions with admis-
sion order placed only after the procedure. Following the
coding guidelines, an intraoperative stroke during carotid
intervention should then be coded as a complication
code of stroke with a POA label. While the goal of the
Centers for Medicare and Medicaid Services pay-for-
performance policy was to differentiate pre-admission
conditions (unrelated to hospital stay) from conditions or
complications that develop during the hospital stay (and
can be, thus, attributed to medical or surgical manage-
ment), this interpretation is not applicable to a large
proportion of carotid procedures. Therefore, the codingof such intraoperative strokes is confusing and potentially
subject to error. This is reﬂected by an inconsistency in
the proportion of strokes that would have occurred intra-
operative in the SID (54% of all CEA strokes and 62% of
all CAS strokes) compared with the proportion of intra-
operative stroke identiﬁed in the Society for Vascular
Surgery vascular registry (16% of all CEA and 33% of all
CAS strokes)12 and in a large institutional review (15% of
all CEA strokes).15
While it is unclear what proportion of patients are
admitted before or after their procedure, many will inter-
pret POA events as preoperative comorbidities and condi-
tions without a POA label as periprocedural events.11
Although the POA indicator was never validated by physi-
cian chart review, this POA methodology has the potential
to improve outcome analyses based on administrative data
compared with traditional methodologies. However, in all
methodologies that were examined in this study, we iden-
tiﬁed serious shortcomings. The most important limitation
of the POA method is that the POA indicator eliminates
the ability to detect a second (perioperative) stroke in those
patients who have a stroke complication code labeled POA.
Under the assumption that this stroke represents a symp-
tomatic patient, all perioperative events in this exception-
ally high-risk group of patients would be missed. This
also translates to a reduced apparent perioperative stroke
rate for the method POA even in comparison to methods
A and B, of which method A is known to underestimate
perioperative strokes.3-5,14
Table III. Frequencies of diagnosis and complication codes used in the State Inpatient Databases of California, New
York, and New Jersey in 3688 patients undergoing carotid endarterectomy (CEA) and the impact of the present on
admission (POA) indicator on preoperative conditions and perioperative outcome
Rates identiﬁed without
POA indicator Proportion POAa
Revised rates with
POA indicator
% No. % No. POA rate,b % Non-POA rate,c %
Major neurologic or acute cardiac diagnoses that may represent either pre-existing conditions or complications after intervention
Stroke
Diagnosis code 15.6 574 91.3 524 14.2 1.4
Complication code 2.4 87 62.1 54 1.5 0.9
Transient ischemic attack 3.4 125 93.6 117 3.2 0.2
Amaurosis fugax 3.4 126 95.2 120 3.3 0.2
Cardiac complication 3.4 125 61.6 77 2.1 1.3
Acute myocardial infarction 2.8 103 73.8 76 2.1 0.7
Conditions that are infrequently encountered after intervention
Peripheral vascular complication 0.3 12 58.3 #10 0.2 0.1
Respiratory complication 0.4 15 40.0 #10 0.2 0.2
Pneumonia 1.8 67 58.2 39 1.1 0.8
Acute renal failure 2.9 108 56.5 61 1.7 1.3
Conditions that are regularly pre-existing comorbidities
Coronary artery disease 33.4 1230 96.3 1185 32.1 1.2
Angina 2.2 81 91.6 76 2.1 0.1
Congestive heart failure 15.6 575 93.9 540 14.6 0.9
Chronic obstructive pulmonary disease 23.1 853 96.2 821 22.3 0.9
Chronic kidney disease 12.0 441 97.3 429 11.6 0.3
Diabetes 47.9 1766 98.2 1735 47.0 0.8
aOf the rates that were identiﬁed without the use of the POA indicator.
bCondition ﬂagged POA.
cCondition not ﬂagged POA.
Table IV. Symptom status of patients undergoing
carotid endarterectomy (CEA) or carotid angioplasty and
stenting (CAS) using different methodologies (A, present
on admission [POA], and B)
Method A Method POA Method B
No. % No. % No. %
CEA
Symptomatic 3436 15.9 3324 15.4 1540 7.1
Asymptomatic 18,203 84.1 18,315 84.6 20,099 92.9
CAS
Symptomatic 801 21.7 776 21.0 243 4.6
Asymptomatic 2887 78.3 2912 79.0 3445 95.4
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edly high proportion of asymptomatic patients in theNation-
wide Inpatient Sample (NIS) was recently criticized.1,2
The reported periprocedural stroke rate in these studies
was lower than in major randomized controlled trials
(RCTs) such as the Carotid Revascularization Endar-
terectomy vs Stenting Trial (CREST).16 This is unex-
pected because these RCTs were executed in ideal
circumstances with highly selected patients, surgeons, and
interventionalists. Using administrative data, mortality rate
following CEA was higher in nontrial hospitals compared
with death rates in a trial setting.17 We found that the ratio
of stroke to death after CEA and CAS in SID was one-halfthat or less compared with the combined stroke-to-death
ratios of three major RCTs among symptomatic patients
(CEA 1.9:1 in SID vs 3.8:1 in RCTs; CAS 0.6:1 in SID vs
4.3:1 in RCTs).18 However, the NIS and SID capture only
in-hospital outcome while the RCTs were based on 30-day
outcome. A recent report from our group found that over
30% of strokes happen after discharge but within 30 days of
surgery.19 These ﬁndings indicate that the nonfatal outcome
of stroke is under-reported in administrative databases partic-
ularly in comparison to mortality, which is a more readily
deﬁnable endpoint.
Similarly, symptom status is unreliable in administrative
data.3,20 Using the POA method, we calculated that 15% of
CEAs and 21% of CAS procedures were performed in
symptomatic patients. In other large vascular registries
such as the Vascular Study Group of New England, one-
third of patients were reported as being symptomatic.21
The Society for Vascular Surgery vascular registry reported
even higher rates between 40% and 50%.12,16 The low rates
found with the POA methodology thus do not ameliorate
concerns regarding the use of administrative data to assign
symptom status to patients undergoing carotid revasculari-
zation. Although it is highly unlikely that the NIS data
represents the true proportion of symptomatic patients
undergoing carotid revascularization in the United States,
certain societal guidelines still draw heavily on data derived
from these administrative studies.22 Though the inclusion
of administrative data to determine societal guidelines is
well intentioned, it may be relying on inaccurate data.23
Table V. Stroke and death rate in patients undergoing carotid endarterectomy (CEA) or carotid angioplasty and stenting
(CAS) using different methodologies (A, present on admission [POA], and B)
Method A Method POA Method B
Stroke, % Death, % Stroke:death Stroke, % Death, % Stroke:death Stroke, % Death, % Stroke:death
CEA
All patients 1.4 0.5 2.8:1 1.1 0.5 2.2:1 9.5 0.5 19:1
Symptomatic 5.9 1.4 4.2:1 2.5 1.3 1.9:1 4.8 0.5 9.6:1
Asymptomatic 0.5 0.4 1.3:1 0.9 0.4 2.3:1 9.9 0.5 19.8:1
CAS
All patients 2.4 1.5 1.6:1 1.8 1.5 1.2:1 16.4 1.5 9.4:1
Symptomatic 7.5 5.6 1.3:1 3.4 5.3 0.6:1 7.4 0.8 10.5:1
Asymptomatic 0.9 0.4 2.3:1 1.4 0.5 2.8:1 17.0 1.6 9.5:1
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administrative data accuracy may conﬁrm the generaliz-
ability of RCTs to a broad spectrum of healthcare centers.
In our opinion, the only way to improve the reliability
of administrative data for carotid interventions is to use
diagnosis codes strictly for pre-existing conditions and
complication codes strictly for postoperative outcome. In
the ICD, Tenth Revision coding system (goal implementa-
tion by October 2014), the current ICD-9 “complication”
code for stroke will be converted to a new code that will
further deﬁne whether a complication of stroke occurred
intraoperatively or postoperatively, with the addition of
stroke laterality. Under this system, if the diagnosis codes
for stroke were used for preoperative symptoms, the POA
indicator would not be needed for carotid interventions.
This methodology will also take away the possibility of
miscoding an intraoperative event as a preoperative condi-
tion. Until the ICD, Tenth Revision is implemented, the
NIS and SID are inappropriate for analysis of stroke
risk outcomes. However, the POA indicator is still of
general interest for hospital and/or surgeon quality
improvement programs and for pay-for-performance initia-
tives, as this assists in appropriately categorizing reimburse-
ment diagnosis-related groups and calculating hospital
reimbursements.
This study must be interpreted in the context of its
design, including the inherent limitations of administrative
data as discussed in this manuscript. The POA indicator
is subject to coding error with improved accuracy for
chronic conditions as compared to acute conditions.24
Although no evidence was found of systematic undercod-
ing of POA, we limited our analyses to those patients
with at least one diagnosis listed as POA to minimize
coding errors on POA information. Finally, administrative
data do not capture anatomic risk factors such as severity
of carotid stenosis nor do they provide detailed information
regarding preoperative symptoms such as laterality,
frequency, or severity. However, it is unlikely that these
limitations of administrative data had a signiﬁcant effect
on our overall ﬁndings.
In conclusion, we found that the vast majority of diag-
nosis codes and nearly one-half of complication codes for
stroke were coded POA. Whether with the POA indicatoror previously described methods for assignment of
symptom status or perioperative strokes, administrative
data appear to signiﬁcantly underestimate the proportion
of symptomatic patients undergoing carotid revasculariza-
tion and the proportion of patients suffering perioperative
strokes in comparison to RCTs and other clinical registries
of vascular surgery. This demonstrates a persistent concern
about the validity of administrative data in deﬁning
symptom status and perioperative outcome after CEA
and CAS. The primary beneﬁt of this analysis is that it
provides further evidence that administrative data have
limited usefulness for nonfatal outcome analysis after
CEA and CAS.
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Supplementary Table I (online only). International Classiﬁcation of Diseases, Ninth Revision (ICD-9) codes used
throughout the manuscript to evaluate comorbidities with and without present on admission (POA) information
Symptom ICD-9 code
Angina 4111
Acute myocardial infarction 410, 41000, 41001, 41010, 41011, 41020, 41021, 41030, 41031, 41040, 41041, 41050, 41051, 41060,
41061, 41070, 41071, 41080, 41081, 41090, 41091
Coronary artery disease 4110, 4111, 4118, 41181, 4119, 4130, 4131, 4139, V4581, V4582
Congestive heart failure 4280, 4281, 42820, 42821, 42822, 42823, 42830, 42831, 42832, 42833, 42840, 42841, 42842, 42843,
4289, 40201, 40211, 40291, 40401, 40403, 40411, 40413, 40491, 40493
COPD 490, 4910, 4911, 49120, 49121, 49122, 4918, 4919, 4920, 4928, 4930, 4931, 49320, 49321, 49322,
4940, 4941, 4950, 4951, 4952, 4953, 4954, 4955, 4956, 4957, 4958, 4959, 496
Pneumonia 4801, 4803, 4808, 4809, 481, 4820, 4821, 4822, 48230, 48231, 48232, 48239, 48240, 48241, 48242,
48249, 4828, 48281, 48282, 48283, 48284,48289, 4829, 4830, 4831, 4838, 484, 4841, 4843, 4845,
4846, 4847, 4848,485,486, 4870, 4871,4878,488
Chronic kidney disease 5853, 5854, 5855, 5856, 5859, 586, V420, V451, V4511, V4512,V560,V561, V562, V563m V5631,
V5632
Acute renal failure 584, 5845, 5846, 5847, 5848, 5849
Diabetes 25000, 25001, 25002, 25010, 25011, 25012, 25013, 25020, 25021, 25022, 25023, 25030, 25031,
25032, 25033, 25040, 25041, 25042, 25043, 25050, 25051, 25052, 25053, 25060, 25061, 25062,
25063, 25070, 25071, 25072, 25073, 25080, 25081, 25082, 25083, 25090, 25091, 25092, 25093
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Volume 59, Number 1 Fokkema et al 38.e1COPD, Chronic obstructive pulmonary disease.Supplementary Table II (online only). International Classiﬁcation of Diseases, Ninth Revision (ICD-9) codes used
throughout the manuscript to evaluate symptom status and perioperative complications with and without present on
admission (POA) information
Symptom ICD-9 code Description
Stroke 99702a Iatrogenic cerebrovascular infarction or hemorrhage
43301 Occlusion and stenosis of basilar artery with cerebral infarction
43311 Occlusion and stenosis of carotid artery with cerebral infarction
43321 Occlusion and stenosis of vertebral artery with cerebral infarction
43331 Occlusion and stenosis of multiple and bilateral precerebral arteries with cerebral infarction
43381 Occlusion and stenosis of other speciﬁed precerebral artery with cerebral infarction
43391 Occlusion and stenosis of unspeciﬁed precerebral artery with cerebral infarction
43401 Cerebral thrombosis with infarction
43411 Cerebral embolism with infarction
43491 Cerebral artery occlusion, unspeciﬁed with infarction
431 Intracerebral hemorrhage
3429 Hemiplegia, unspeciﬁed, affecting unspeciﬁed side
36231 Central retinal artery occlusion
36232 Retinal arterial branch occlusion
4371 Other generalized ischemic cerebrovascular disease
Transient ischemic attack 4350 Basilar artery syndrome
4351 Vertebral artery syndrome
4352 Subclavian steal syndrome
4353 Vertebrobasilar artery syndrome
4358 Other speciﬁed transient cerebral ischemias
4359 Unspeciﬁed transient cerebral ischemia
7814 Transient paralysis of limb
Amaurosis fugax 36234 Transient retinal arterial occlusion
36812 Transient visual loss
36284 Retinal ischemia
aThe “complication code” for stroke.
